Lecture 3: Drugs to Treat Type I Diabetes

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/54

encourage image

There's no tags or description

Looks like no tags are added yet.

55 Terms

1
New cards

Insulin

-Released by beta-cells in islets of Langerhans in response to increased blood glucose

• Basal amount secreted throughout the day (basal secretion)

• Increases in insulin secretion in response to food intake (prandial secretion)

• Promotes uptake of glucose into cells for use as energy or storage

2
New cards

Glucagon

Released by alpha-cells in the islets of Langerhans in response to decreased blood glucose

3
New cards

Amylin

Peptide hormone co-secreted by pancreatic beta cells with insulin

4
New cards

Prevent or delay the progression of long-term micro- and macrovascular complications

primary goal of therapy for diabetes mellitus

5
New cards

1%

A ______% reduction in A1C results in risk reduction of: 37% for microvascular complications, 14% for myocardial infarction, and 21% for death.

6
New cards

• Alleviate symptoms of hyperglycemia

• Minimize hypoglycemia and other adverse effects

• Minimize treatment burden

• Maintain quality of life

secondary goals of therapy for diabetes mellitus

7
New cards

7%

Goal:

Hemoglobin A1C < _______%

8
New cards

80-130

Goal:

Pre-prandial plasma glucose: ________ mg/dL

9
New cards

180

Goal;

Peak post-prandial plasma glucose:

10
New cards

• Corticosteroids

• Loop diuretics

• Thiazide diuretics

• Phenytoin

• b-blockers

medications that increase plasma glucose

11
New cards

• Other antihyperglycemic medications

• Alcohol

• Salicylates

• Fluoroquinolones

• Antidepressants

medications that increase hypoglycemia

12
New cards

Beta-Blockers

drugs that increase plasma glucose, and therefore mask the symptoms of hypoglycemia

13
New cards

Somatostatin Analogues

-inhibit insulin and glucagon secretion

14
New cards

Rapid-acting

Regular (short-acting)

Intermediate-acting

Long-acting

Ultra Long-Acting

what are the types of insulin?

15
New cards

Oral Insulin

What formulations cannot be utilized due to poor absorption and enzymatic degradation within the gastrointestinal tract?

16
New cards

• Hypoglycemia

• Weight gain

• Lipodystrophy

• Hypokalemia

Adverse reactions of insulin

17
New cards

Akt

-regulates the activity of GLUT4 and PKC which plays a critical role in metabolism and catabolism

18
New cards

• PO Glucose

-Orange juice, candy, etc.

-Recheck blood sugar

-Repeat if needed

treatment for a hypoglycemic pt that is conscious

19
New cards

• IV Dextrose

OR

• IM Glucagon (1mg)

treatment for a hypoglycemic pt that is unconscious

20
New cards

2.5 minutes

ultra rapid acting insulin reaches the blood in ________________

21
New cards

Subcutaneous Injection

what is the most common route for insulin administration

22
New cards

Basal Insulin

• Controls blood glucose in the fasting state

• Mimics basal or baseline pancreatic insulin secretion

• Insulin given to control hepatic glucose production in the absence of food

• Dose often reduced (~50%) when patients NPO

• Approximately 50% of daily insulin requirements

23
New cards

Intermediate or long-acting

which insulin is used to

provide basal insulin coverage, with delayed

absorption and a longer duration of activity (basal insulin)?

24
New cards

Bolus Insulin

• Controls blood glucose spikes surrounding mealtimes

• Mimics postprandial insulin pancreatic secretion when blood glucose rises after food ingestion

• Insulin given to limits hyperglycemia after meals

• Approximately 50% of daily insulin requirements

• 10-20% of daily requirement at each meal

25
New cards

Rapid or Short Acting

which insulin is used for immediate coverage for a rapid rise in blood glucose, with a sharp peak and shorter duration of activity (bolus)?

26
New cards

Prandial

scheduled insulin administered prior to meals, to cover planned meal intake of carbohydrates

27
New cards

Correctional (supplemental)

corrects hyperglycemia detected before or between meals based on BG monitoring

28
New cards

Insulin aspart (Fiasp)

-ultra rapid-acting insulin

-contains form of vitamin B3 (niacinamide), which increases the speed of initial insulin absorption, and an amino acid to aid stability.

29
New cards

Insulin aspart (Fiasp)

• Onset of action: 2-15 min

• Increased solubility --> rapid dissociation

• Duration of action: 4-5 hours

-improve glycemic control

• Administration: at beginning or within 20 minutes of a minutes of a meal

30
New cards

• Mealtime insulin replacement

• Carbohydrate intake

considerations for dosing of ultra-rapid and rapid Insulin

31
New cards

Insulin humanis-inhaled (Afrezza)

-ultra-rapid acting insulin

• Onset of action: 5-12 min

• Duration of action: 1.5-4.5 hours

32
New cards

Insulin humanis-inhaled (Afrezza)

• Diabetes mellitus, types 1 and 2, treatment:

• BBW: Acute bronchospasm in chronic lung disease = Contraindicated

• Rapid-acting for inhalation before meals

• Inferior to injection comparing A1C

• Lower hypoglycemia risk

33
New cards

-Insulin lispro (Humalog)

-Insulin aspart (NovoLog)

-Insulin glulisine (Apidra)

Rapid-Acting Insulins

34
New cards

-Insulin aspart (Fiasp)

-Insulin humanis-inhaled (Afrezza)

Ultra-Rapid Insulins

35
New cards

Rapid-Acting Insulin

• Modification of 1-2 amino acids on B chain

• Onset of action: 10-20 min

• Duration of action: 3-6 hours

-Control of post-prandial glucose levels

• Administration: 10-15 minutes before meals

• Helps to reduce hypoglycemia risk

36
New cards

Regular Insulin (short-acting)

-recombinant human protein

• Onset of action: 30 min

• Duration of action: 5- 8 hours

-Control of glucose levels

• Administration: 30 minutes before meals

37
New cards

U-500 (Unique Intermediate Acting Insulin)

-concentrated regular insulin with prolonged duration

-onset: 15-30 min

-basal and bolus

• Eliminates need for separate basal and bolus agents

• Dosed 2-3 times a day

• Often considered for patients with high insulin requirements & resistance by diabetes specialist

• High risk medication

38
New cards

Neutral protamine Hagedorn (NPH)

-Intermediate-Acting Insulin

-Complexed insulin-zinc precipitated with protamine for decrease solubility and delay absorption

• Onset of action: 1-2 hours

• Duration of action: 16-24 hours

-Basal control of glucose levels

-Administration: Two times per day in regard to meals

39
New cards

AM and PM

when is NPH administered?

40
New cards

-Insulin glargine

-Insulin detemir

-Insulin glargine

Long-Acting Insulins

41
New cards

Insulin detemir

long acting insulin that has an addition of myrisitc acid to the A chain

-makes it a stable precipitate

42
New cards

Long-Acting Insulins

Role in therapy:

• Basal control of glucose levels

• Have higher hypoglycemia risk

• Generally dosed 1 time per day

43
New cards

Insulin degludec

-Ultra Long-Acting Insulin

• Recombinant, stabilized form with large particle size

• Onset of action: 30-90 min

• Duration of action: 42 hours

44
New cards

Insulin degludec

-Basal control of glucose levels

• Administration: One time per day

• Have higher hypoglycemia risk

45
New cards

Insulin glargine

Which long acting insulin develops over 6 hours and lasts for > 24 hours

46
New cards

Dosing pens

-type of insulin preparation

• Designed for ease of dosing

• Easy to transport

• No refrigeration required

47
New cards

0.4-0.5

Recommended starting daily dose of insulin for T1DM: _____________units/kg/day

48
New cards

Neutral protamine Hagedorn (NPH)

______________ regimens = Higher risk for hypoglycemia

49
New cards

Continuous subcutaneous insulin infusion (CSII)

-Intensive glycemic control for adherent patients

-pt must be motivated, adherent, and competent to use the device

-typically utilizes rapid-acting insulin

50
New cards

Insulin to carbohydrate ratio (I:C)

• Estimated units of insulin required per

carbohydrate amount

• Used to determine pre-meal dosing

• Estimated: 550 / TDD

51
New cards

Insulin sensitivity factor (ISF)

• Estimated glucose lowering expected from 1 unit of insulin

• Used for "correctional insulin" calculation, also sometimes called CF (correction factor)

• Estimated: 1650 / TDD

52
New cards

Pramlintide

• MOA: Amylin analog

-adjunctive therapy for T1DM

• Delays gastric emptying, decreases glucagon secretion, increases satiety

• Decreases A1C

• Lowers insulin doses

53
New cards

Teplizumab

Drug That Can Delay Onset of Type 1 Diabetes

54
New cards

Teplizumab

-immunomodulatory monoclonal antibody works by binding to CD3 to delay the onset of stage 3 T1D

-with their CD3 activation

and function

55
New cards

• Restoration of intravascular volume

• Electrolyte replacement

• Insulin given by continuous IV infusion (regular insulin used)

• Generally, avoid administration of bicarbonate

treatment for Diabetic Ketoacidosis (DKA)